-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) PT Lowered to $35 at Jefferies
-
-
-
-
-
-
-
Pre-Open Stock Movers 02/07: (IRBT) (LCI) (STI) Higher; (SLDB) (OSUR) (GRUB) Lower (more...)
-
-
-
-
-
-
-
Jefferies Sees Limited Impact for PTC Therapeutics (PTCT) After Sarepta's Eteplirsen was Approved
-
-
-
-
-
-
-
Jefferies Continues to See Low Probablity of Sarepta (SRPT) Approval
-
-
-
-
-
-
-
Notable Analyst Rating Changes 4/29: (ALXN) (WNS) (CE) Upgraded; (WYNN) (SRPT) (DB) Downgraded
-
-
-
-
-
-
-
Jefferies Survey Suggests Positive Expectations for BioMarin (BMRN) Ahead of Data on 11/24
-
-
-
-
-
-
-
Pre-Open Stock Movers 10/01: (TKMR) (HEB) (ANGI) Higher; (FNMA) (FMCC) (WPRT) Lower (more...)
-
73,350 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

